Tissue factor pathway inhibitor in infants and children

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026

Clinical Predictors of Time to Hospital Discharge in Children With New-Onset Diabetic Ketoacidosis in Zambia: A Retrospective Cohort Study.

Endocrinology, diabetes & metabolism·2026

[Six-Years Human Parvovirus B19 Data from a University Hospital: Analysis of the Recent Increase in Case Numbers].

Mikrobiyoloji bulteni·2026

The spaces in between: silence as a witness to accompaniment in congenital heart disease.

Cardiology in the young·2026

Trends in Incidence and Premature Mortality (Years of Life Lost) From Acute Viral Hepatitis Among Children Under Five in Ethiopia, From 1990 to 2023: A Global Burden of Disease 2023 Study.

Global health, epidemiology and genomics·2026

Related Experiment Videos

Tissue factor pathway inhibitor in infants and children

Related Concept Videos

Anticoagulation in patients with impaired renal function and with haemodialysis.

A fluorescent probe assay (Heparin Red) for direct detection of heparins in human plasma.

Biosimilars of low-molecular-weight heparin products: fostering competition or reducing 'biodiversity'?

Anticoagulation in patients with impaired renal function and with haemodialysis. Anticoagulant effects, efficacy, safety, therapeutic options.

Clinical trials with new oral anticoagulants. Additive value of indirect comparisons also named network meta-analyses.

Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.

Phenotypic and glycosylation profiles of the FGG c.902G > A (p.Arg301His) mutation in a Chinese pedigree with congenital dysfibrinogenemia.

Descriptive analysis of the Nationwide START2 antiphospholipid registry: Clinical and laboratory characteristics of patients with persistently positive antiphospholipid antibodies.

Prevalence of iron deficiency in reproductive-age females on anticoagulation.

Who says "no" - Patient-specific risk factors for refusal of venous thromboembolism chemoprophylaxis in hospitalized patients.

Diverse antiphospholipid syndromes and beyond: A multicenter comprehensive analysis from the Egyptian College of Rheumatology.

Risk of venous thromboembolism in first-degree relatives of affected patients compared with general population.

Factors Associated With Likelihood of Experiencing a Pediatric Safety Event in the Inpatient Setting.

The Association Between Obesity and ICU Duration in Pediatric Critical Asthma.

Clinical Predictors of Time to Hospital Discharge in Children With New-Onset Diabetic Ketoacidosis in Zambia: A Retrospective Cohort Study.

[Six-Years Human Parvovirus B19 Data from a University Hospital: Analysis of the Recent Increase in Case Numbers].

The spaces in between: silence as a witness to accompaniment in congenital heart disease.

Trends in Incidence and Premature Mortality (Years of Life Lost) From Acute Viral Hepatitis Among Children Under Five in Ethiopia, From 1990 to 2023: A Global Burden of Disease 2023 Study.

Related Experiment Videos

Tissue factor pathway inhibitor in infants and children

Related Concept Videos

Related Articles